This site is intended for health professionals only

Sanofi pulls US rimonabant application

teaser

Article continues below this sponsored advert
Cogora InRead Image
Explore the latest advances in respiratory care at events delivered by renowned experts from CofE
Advertisement

It comes as no surprise but Sanofi-Aventis has withdrawn its marketing application to gain approval in the USA for its obesity drug Acomplia






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

×